Model
Edge
Citius Pharmaceuticals Inc.
CTXR
Filing Type
8-K
Filing Date
5/7/2026
Updated
5/8/26, 2:35 PM
Filing
8-K
Earnings Release
Exhibits
8-K
Material Contracts
EX-10.1
THIRD AMENDMENT TO PROMISSORY NOTE, DATED AS OF MAY 4, 2026, BETWEEN THE COMPANY AND CITIUS ONCOLOGY